Mylan N.V. (NASDAQ:MYL) was the recipient of some unusual options trading on Wednesday. Investors purchased 10,562 put options on the company. This is an increase of 461% compared to the typical daily volume of 1,883 put options.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MYL. Global X Management Co. LLC raised its holdings in Mylan N.V. by 91.6% in the 1st quarter. Global X Management Co. LLC now owns 3,015 shares of the company’s stock worth $118,000 after purchasing an additional 1,441 shares during the period. TLP Group LLC acquired a new position in Mylan N.V. in the 1st quarter worth about $200,000. Doliver Capital Advisors LP acquired a new position in Mylan N.V. in the 2nd quarter worth about $201,000. Eagle Global Advisors LLC acquired a new position in Mylan N.V. in the 2nd quarter worth about $205,000. Finally, Sheaff Brock Investment Advisors LLC acquired a new position in Mylan N.V. in the 2nd quarter worth about $210,000. 71.97% of the stock is owned by institutional investors.

MYL has been the topic of a number of research analyst reports. UBS AG reaffirmed a “buy” rating and set a $46.00 price target (down from $50.00) on shares of Mylan N.V. in a report on Thursday, August 10th. Citigroup Inc. raised Mylan N.V. from a “neutral” rating to a “buy” rating and upped their price target for the company from $36.00 to $42.00 in a report on Wednesday, August 16th. Mizuho reaffirmed a “buy” rating and set a $37.00 price target (down from $53.00) on shares of Mylan N.V. in a report on Sunday, August 20th. BMO Capital Markets reaffirmed a “buy” rating and set a $45.00 price target on shares of Mylan N.V. in a report on Friday, September 29th. Finally, ValuEngine raised Mylan N.V. from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $41.99.

Shares of Mylan N.V. (NASDAQ:MYL) opened at 38.29 on Friday. Mylan N.V. has a 12 month low of $29.39 and a 12 month high of $45.87. The stock has a market cap of $20.53 billion, a PE ratio of 30.95 and a beta of 1.30. The firm has a 50-day moving average price of $32.08 and a 200-day moving average price of $36.45.

Mylan N.V. (NASDAQ:MYL) last issued its quarterly earnings data on Wednesday, August 9th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.18 by ($0.08). The company had revenue of $2.96 billion during the quarter, compared to analyst estimates of $3 billion. Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. The business’s quarterly revenue was up 15.7% compared to the same quarter last year. During the same period last year, the firm earned $1.16 EPS. Equities analysts forecast that Mylan N.V. will post $4.57 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Stock Traders Buy High Volume of Put Options on Mylan N.V. (MYL)” was first reported by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this news story can be viewed at https://www.watchlistnews.com/stock-traders-buy-high-volume-of-put-options-on-mylan-n-v-myl/1613953.html.

Mylan N.V. Company Profile

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.